Ruth Gilmore

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders

Flora Peyvandi, Roberta Palla, Marzia Menegatti et al. · Journal of Thrombosis and Haemostasis · 2012 · 488 citations · Full text

Thrombosis, Coagulation Factor Activity, Medicine +11

Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE®)

Christopher L. Bacon, Evelyn Singleton, Bethany L. Brady et al. · Haemophilia · 2011 · 34 citations

Immunology, Pathology, Pharmacotherapy +16

Chemokines Are Present in the Genital Tract of HIV-Seropositive and HIV-Seronegative Women

Gregory T. Spear, Beverly E. Sha, Mary Nel Saarloos et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 1998 · 24 citations

Immunodeficiencies, Immunology, Genital Tract +21

Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy

Ruth Gilmore, S. HARMON, Craig Gannon et al. · Haemophilia · 2010 · 23 citations

A <scp>V</scp>740<scp>L</scp> mutation in glycoprotein <scp>IIb</scp> defines a novel epitope (<scp>W</scp>ar) associated with fetomaternal alloimmune thrombocytopenia

Anthony Poles, Marcin Woźniak, Piers J. Walser et al. · Transfusion · 2013 · 16 citations · Full text